Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines

Journal of Surgical Research

Volumn 61, Issue 1, 1996, Pages 127-133

  Evans, Stephen R T ^a   Houghton, A Mcgarry ^a   Schumaker, Lisa ^a   Brenner, Richard V ^a   Buras, Robert R ^a   Davoodi, Fatemeh ^a   Nauta, Russell J ^a   Shabahang, Mohsen ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; VITAMIN D; VITAMIN RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0030043439     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0092     Document Type: Article

References (37)

1. 3. Nutr. Rev. 43: 161-168, 1985.
2. Haussler, M. R., Mangelsdorf, D. H., Komm, B. S., Terpening, C. M., Yamaoka, K., Allegretto, E. A., Baker, A. R., Shine, J., McDonnell, D. P., Hughis, M., Weigel, N. L., O'Malley, B. W., and Pike, J. W. Molecular biology of the vitamin D hormone. Recent Prog. Horm. Res. 44: 263-305, 1992.
3. Baker, A. R., McDonnell, D. P., Hughes, M., Crisp, T. M., Mangelsdorf, D. J., Haussler, M. R., Pike, J. W., Shine, J., and O'Malley, B. W. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. USA 85: 3294-3298, 1988.
4. Norman, A. W. Vitamin D research frontiers. J. Cell. Biochem. 49: 1-3, 1992.
5. 3 receptors: gene regulation and genetic circuitry. FASEB J. 2: 3043-3053, 1988.
6. Reichel, H., Koeffler, H. P., and Norman, A. W. The role of the vitamin D endocrine system in health and disease. New Engl. J. Med. 320: 980-991, 1989.
7. Pike, J. W., Gooze, L. L., and Haussler, M. R. Biochemical evidence for 1,25-dihydroxyvitamin D receptor macromolecules in parathyroid, pancreatic, pituitary, and placental tissues. Life Sci. 26: 407-414, 1980.
8. 3 receptors in human epithilial cancer cell lines. Cancer Res. 42: 856-859, 1982.
9. 3 receptors in established human cancer cell lines in culture. Cancer Res. 42: 1116-1119, 1982.
10. 3. Proc. Natl. Acad. Sci. USA 78: 4990-4994, 1981.
11. 3 metabolites. Cancer Res. 43: 4443-4447, 1983.
12. 3 as a marker of human colon carcinima cell line differentiation and growth inhibition. Cancer Res. 53: 3712-3719, 1993.
13. 3 on human cancer cells in vitro. J. Steroid Biochem. 27: 825-828, 1987.
14. Mansur, C. P., Gordon, P. R., Ray, S., Holick, M. F., and Gilchrest, B. A. Vitamin D, its precursors, and metabolites do not affect melanization of cultured human melanocytes. J. Invest. Dermatol. 91: 16-21, 1988.
15. 3, alpha-melanocyte stimulating hormone, and beta-estradiol. J. Invest. Dermatol. 91: 593-598, 1988.
16. Kragballe, K. Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903). Arch. Dermatol. 125: 1647-1652, 1989.
17. 3 receptors in normal and psoriatic skin. J. Invest. Dermatol. 97: 230-239, 1991.
18. 3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 108: 1083-1086, 1981.
19. Mason, R. S., Pryke, A. M., Ranson, M., Thomas, H. E., and Posen, S. Human melanoma cells: functional modulation by calciotropic hormones. J. Invest. Dermatol. 90: 834-840, 1988.
20. 3. Cancer Res. 47: 1-25, 1987.
21. 3 receptor in mammalian cells using recombinant adenovirus vectors. Mol. Endocrinol. 5:867-878, 1991.
22. Sambrook, J., Fritsch, E. F., and Maniatis, T. Extraction, purification, and analysis of messenger RNA from eukaryotic cells. In Molecular Cloning: A Laboratory Manual (2nd ed.), p. 7.19. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
23. Laborda, J. 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res. 19: 3998, 1991.
24. Scatchard, G. The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci. 51: 660-672, 1949.
25. Diffey, B. L. Solar ultraviolet radiation effects on biological systems. Phys. Med. Biol. 36: 299-328, 1991.
26. Herlyn, M. Molecular and Cellular Biology of Melanoma, pp. 1-23. Austin, TX: RG Landes Company, 1993.
27. Weinstock, M. A., Stampfer, M. J., Lew, R. A., Willett, W. C., and Sober, A. J. Case-control study of melanoma and dietary vitamin D: implications for advocacy of sun protection and sunscreen use. J. Invest. Dermatol. 98: 809-811, 1992.
28. 3. Ann. NY Acad. Sci. 548: 14-26, 1988.
29. 3 on epidermal melanocytes. J. Cell. Physiol. 136: 273-280, 1988.
30. Hughes, M., Malloy, P., Kieback, D., McDonnell, D., Feldman, D., Pike, J. W., and O'Malley, B. Human vitamin D receptor mutations: identification of molecular defects in hypocalcemic vitamin D resistant rickets. Adv. Exp. Med. Biol. 255: 491-503, 1989.
31. Roman, S. D., Clarke, C. L., Hall, R. E., Alexander, I. E., and Sutherland, R. L. Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res. 52: 2236-2242, 1992.
32. Gaspar, M. L., Meo, T., Bourgarel, P., Guenet, J. L., and Tosi, M. A single base deletion in the Tfm androgen receptor gene creates a short-lived messenger RNA that directs internal translation initiation. Proc. Natl. Acad. Sci. USA 88: 8606-8610, 1991.
33. Karnik, P. S., Kulkarni, S., Liu, X. P., Budd, G. T., and Bukowski, R. M. Estrogen receptor mutations in tamoxifen-resistant breast cancer. Cancer Res. 54: 349-353, 1994.
34. Pfeffer, U., Fecarotta, E., Castagnetta, L., and Vidali, G. Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines. Cancer Res. 53: 741-743, 1993.
35. Wang, Y., and Miksicek, R. J. Identification of a dominant negative form of the human estrogen receptor. Mol. Endocrinol. 5: 1707-1715, 1991.
36. Morrison, N. A., Qi, J. C., Tokita, A., Kelly, P. J., Crofts, L., Nguyen, T. V., Sambrook, P. N., and Eisman, J. A. Prediction of bone density from vitamin D receptor alleles. Nature 367: 284-287, 1994.
37. 3. J. Clin. Invest. 83: 1903-1915, 1989.